{
  "name" : "twin.sci-hub.se_7015_2055958490b2cece0b13d065460b30bc_pallardy2017.pdf",
  "metadata" : {
    "source" : "CRF",
    "title" : null,
    "authors" : [ ],
    "emails" : [ "marc.pallardy@u-psud.fr" ],
    "sections" : [ {
      "heading" : null,
      "text" : "May 2017 | Volume 8 | Article 5441\nMini Review published: 15 May 2017\ndoi: 10.3389/fimmu.2017.00544\nFrontiers in Immunology | www.frontiersin.org\nEdited by: Diana Boraschi,\nConsiglio Nazionale Delle Ricerche (CNR), Italy\nReviewed by: Francesca Granucci,\nUniversity of Milano-Bicocca, Italy Giamila Fantuzzi,\nUniversity of Illinois at Chicago, USA\n*Correspondence: Marc J. Pallardy\nmarc.pallardy@u-psud.fr\nSpecialty section: This article was submitted\nto Inflammation, a section of the journal\nFrontiers in Immunology\nReceived: 29 March 2017 Accepted: 24 April 2017 Published: 15 May 2017\nCitation: Pallardy MJ, Turbica I and\nBiola-Vidamment A (2017) Why the Immune System Should Be\nConcerned by Nanomaterials? Front. Immunol. 8:544.\ndoi: 10.3389/fimmu.2017.00544\nwhy the immune System Should Be Concerned by nanomaterials? Marc J. Pallardy*, Isabelle Turbica and Armelle Biola-Vidamment\n“Inflammation, Chimiokines and Immunopathology”, INSERM UMR 996, Univ Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France\nParticles possess huge specific surface area and therefore nanomaterials exhibit unique characteristics, such as special physical properties and chemical hyper-reactivity, which make them particularly attractive but also raise numerous questions concerning their safety. Interactions of nanomaterials with the immune system can potentially lead to immunosuppression, hypersensitivity (allergy), immunogenicity and autoimmunity, involving both innate and adaptive immune responses. Inherent physical and chemical NP characteristics may influence their immunotoxicity, i.e., the adverse effects that can result from exposure. This review will focus on the possible interaction of nanomaterials including protein aggregates with the innate immune system with specific emphasis on antigen-presenting cells, i.e., dendritic cells, macrophages and monocytes.\nKeywords: nanoparticles, dendritic cells, danger signals, macrophages, innate immunity\ninTRODUCTiOn\nNanoparticles (NP) are defined as structures with at least one dimension in the range of 1–100 nm. At this nanoscale, particles possess huge specific surface area. Nanomaterials therefore exhibit unique characteristics, such as special physical properties and chemical hyper-reactivity, which make them particularly attractive but also raise numerous questions concerning their safety. Nanomaterial interactions with the body include accidental exposure (environmental and industrial NP) and therapeutic exposure (vaccination, drug delivery). Virtually, all the possible routes of exposure (inhalation, ingestion, dermal contact, systemic injection) have to be considered.\nThe main objective of the immune system is to avoid harmful effects due to contamination by microbes and also to maintain an immune tolerance to environmental antigens. To distinguish between harmful and non-harmful antigens, the dendritic cells (DCs) play a major role by sensing the environment and adapting their phenotype to the most appropriate type of response: immunogenic vs. tolerogenic. Interactions of NP with the immune system can potentially lead to immunosuppression, hypersensitivity (allergy), immunogenicity and autoimmunity, involving both innate and adaptive immune responses. Inherent physical and chemical NP characteristics may influence their immunotoxicity, i.e., the adverse effects that can result from exposure. This review will focus on the possible interaction of nanomaterials, including protein aggregates, with the innate immune system with specific emphasis on antigen-presenting cells, i.e., DCs, macrophages and monocytes.\nnP inTeRACTiOn wiTH innATe iMMUne CeLLS\nIn host, the mononuclear phagocytic system plays a major role in the exposure to nanomaterials. Macrophages are in charge of nanomaterials recognition, uptake, processing, and clearance (1). Several in  vivo studies have demonstrated high NPs macrophage sequestration, particularly\nFrontiers in Immunology | www.frontiersin.org May 2017 | Volume 8 | Article 544\nin clearance organs such as liver, spleen, and kidney. In these organs, fenestrated capillary beds, competent to capture particles, are associated with specialized macrophages populations (1). In mice injected with non-degradable silica NPs, a high accumulation in the liver and in the spleen was observed, in majority in the macrophages but also in neutrophils (2). This property could be responsible for organ-specific toxicity, especially in the liver, of some NPs.\nNanoparticles uptake can occur through phagocytosis, macropinocytosis, as well as clathrin-, caveolae-, and scavenger receptor-mediated endocytic pathways. These internalization processes are deeply dependent on nanomaterials properties such as size, shape, surface coating, and on the cellular environment (3). Phagocytosis is carried out by professional phagocytes such as macrophages, neutrophils, DCs, or monocytes. Due to their actin-based cytoskeleton rearrangement capacities, these cells can entrap the material through membrane dynamics in a zipper model fashion (1). The best characterized opsonin-dependent phagocytosis receptors are the Fcγ receptor and the complement receptor CR3, which appear to play a significant role in the detection of opsonized nanomaterials and in the rate of uptake (1). It was demonstrated that the small gold colloid NPs (30 nm) use several internalization routes (including scavenger receptor-, clathrin-, and caveolin-mediated pathways), in contrast to the larger materials of 150 nm which appear to be preferentially taken up via the scavenger receptor pathway (4). The scavenger receptor MARCO has been involved in the ingestion of unopsonized inhaled TiO2 and Fe2O3 particles in the lung (5). Moreover, the recognition of silica NPs by macrophages scavenger A receptor could induce the release of cytokines responsible for pulmonary inflammation (6). The mechanisms for NP uptake by DCs are poorly understood. However, according to Vallhov et  al. (7), an active mechanism such as endocytosis may be involved in the amorphous silica nanoparticle (aSNP) uptake by DCs (7). Winter et al. (8) additionally suggested that it would be at least partly mediated by an actin-dependent mechanism (8).\nNanomaterials can affect the polarization and the reprogramming of macrophages, mostly depending on chemical composition, size, and surface modification (9). The pro-inflammatory M1 or anti-inflammatory M2 phenotypes have been shown to display distinct uptake capacity for nanomaterials. In particular, silica NPs uptake is enhanced in M2-polarized primary human monocyte-derived macrophages or in the macrophage-like THP-1 cell line as compared with M1 cells (10).\nIn vivo, upon exposure to biological fluids, NPs do not stay “naked” but become coated by biomolecules, primarily proteins but also sugars, lipids, or nucleic acids, forming a “corona” (11). This corona is “what the cell sees” and displays a highly dynamic nature: changes in the composition occur over time, in a continuous flux of desorption/adsorption of proteins. If the “hard” corona is tightly bound with a long exchange time, the “soft” corona, presented as a second layer, is submitted to fast exchanges (12, 13). Interestingly, this process could be compared to the opsonization of pathogens (14) and affects the efficiency of NPs uptake by macrophages. Kapralov et al. demonstrated that single-walled carbon nanotubes (SWCNTs) selectively adsorbed phosphatidylcholines and phosphatidylglycerols from lung surfactant. The\npresence of this coating noticeably enhanced the in vitro uptake of SWCNTs by macrophages (15). Moreover, proteins may undergo conformational changes, such as unfolding, leading to the possible exposition of cryptic epitopes recognized by immune cells (14). This unfolding was demonstrated with fibrinogen coated on negatively charged poly(acrylic acid) gold NPs, leading to MAC-1 receptor activation and pro-inflammatory cytokines secretion through NF-κB signaling (16). Interestingly, only the negatively charged NPs induced TNF-α and IL-8 release by THP-1 cells, whereas both positively and negatively charged particles could bind fibrinogen with high affinity (17). This protein corona is essential for scavenger receptor-efficient internalization of synthetic-layered silicate NPs by THP-1 cells (18). When bound to these NPs, albumin undergoes unfolding, comparable to heat denaturation, revealing a cryptic sequence allowing recognition of serum albumin by this family of receptors and nanomaterial recognition by macrophages (18).\nDCs AnD nAnOMATeRiALS AS eXOGenOUS DAnGeR SiGnALS\nDendritic cells are professional antigen-presenting cells that bridge the innate and adaptive immune response. Immature DCs reside in non-lymphoid tissues in an antigen-capturing state. In the presence of various stimuli, such as allergens, inflammation, pro-inflammatory cytokines, bacterial products, or diverse danger signals, DCs undergo a maturation process. This process results in antigen-processing and upregulation of major histocompatibility complex (MHC), co-stimulatory molecules, chemokine, and cytokine receptors, and production of cytokines and chemokines. Mature DCs then migrate to regional lymph nodes and activate naïve T-lymphocytes. Consequently, NP impact on these cells raises growing concerns.\nThe size of the NP may determine the modulation of DC functions. For example, in vivo, 20 nm polystyrene (PS) particles are more frequently captured by lung DCs than 1,000  nm PS particles (19). If the 20 nm PS particle in vitro treatment did not affect murine bone marrow-derived dendritic cells (BM-DCs) cell viability, maturation markers expression, and antigen uptake, these particles significantly downregulated antigen degradation in a size-dependent manner, in association with accumulation in lysosomes but without altering T-cell proliferation (19). Moreover, NPs and materials traffic to the draining lymph nodes also appear to be size-dependent. Indeed, only small particles (20–200 nm) are able to drain freely to the lymph nodes (20).\nIn murine BM-DCs, carbon black NPs upregulate the expression of the cell surface molecules CD86, and slightly CD80 and MHC-II molecules, associated with enhancement of allogenicmixed lymphocyte reaction (21). TiO2 NPs were also demonstrated to increase the expression of CD86, CD80, MHC-II, and TNF-α in murine BM-DCs (22). In murine BM-DCs and in the murine DC line DC 2.4, ultrafine silica NPs decreased cell viability, induced slight phenotypic changes but significantly increased TNF-α production in a size-dependent manner (23). Interestingly, these effects were correlated with inflammatory response in vivo in C57BL/6 mice injected subcutaneously with liquid matrigel\nFiGURe 1 | interaction of nanomaterials and aggregates with DCs. Nanomaterials and aggregates can be internalized by several receptors present at immature DCs membrane, either by endocytic or phagocytic pathways. Protein aggregates will then be processed by DCs, leading to peptide presentation associated with MHC class II molecules to naive T-lymphocytes. Both nanomaterials coated with a corona or protein aggregates may also be seen as NAMPs and interact with PRR. This interaction can act as a danger signal that induces a signaling cascade leading to the transcription of maturation genes. Mature DC will then be able to express co-stimulation molecules and to produce cytokines and chemokines that will trigger naïve T-cells activation and polarization. These products can also increase ROS production and initiate the inflammasome activation. CR, complement receptor; DCs, dendritic cells; FcR, immunoglobulin constant fragment receptor; MHC, major histocompatibility complex; NAMP, nanoparticles-associated molecular patterns; PRR, pattern recognition receptors; ROS, reactive oxygen species; Scavenger R, scavenger receptor; TLR, toll-like receptor.\n3\nPallardy et al. Immune System and Nanomaterials\nFrontiers in Immunology | www.frontiersin.org May 2017 | Volume 8 | Article 544\ncontaining silica NPs (23). Winter et al. (8) studied the effects of aSNPs on murine BM-DCs. Amorphous SNPs were able to affect cell viability through apoptosis and induced partial maturation of BM-DCs as evidenced by enhanced expression of MHC-II and co-stimulatory molecules at the cell surface. Activation of the NLRP3 inflammasome was also reported (8). Taken together, these observations suggest that certain NP may promote DC maturation and activation, thereby leading to T-lymphocytes activation (Figure 1)."
    }, {
      "heading" : "THe “DAnGeR HYPOTHeSiS” APPLieD",
      "text" : ""
    }, {
      "heading" : "TO eXOGenOUS PARTiCLeS AnD nAnOMATeRiALS",
      "text" : "Danger signals of endogenous or exogenous origin activate DCs and stimulate both the innate and adaptative immune responses. As proposed by Gallo and Gallucci, “classic,” “homeostatic,” and “emerging” danger signals can be distinguished (24). Classic danger signals are derived from pathogens and released during infections (pathogen-associated molecular patterns) or result from tissue damage, released by necrotic dying cells (damageassociated molecular patterns or “alarmins”) (25). Homeostatic danger signals are endogenous molecules released during cellular stresses such as hypoxia, acidity, or osmolality perturbations. Chemical sensitizers involved in contact allergy have recently being found to modify the cutaneous microenvironment and/ or directly activate DCs resulting in DC phenotype modifications necessary for immune sensitization to these chemicals (26). Emerging danger signals are newly man-made materials,\nincluding nanomaterials, and may either directly activate DCs or indirectly by inducing tissue damage. Thus, it is postulated that immune cells could sense nanomaterials, which could be designated as nanoparticles-associated molecular patterns (Figure 1) as described for pathogens (14, 24). Sensing of damage signals can be associated with the constitution of inflammasomes, acting as a multiprotein platform to activate caspase-1 and to stimulate the processing of pro-IL-1β. An increase in reactive oxygen species (ROS) production by nanomaterials has been described as an initiating step in the activation of the inflammasome. Interestingly, TiO2 NPs, associated with the generation of ROS in human DCs, promoted cells maturation and pro-inflammatory cytokine release, whereas CeO2 NPs, possessing antioxidant properties, triggered human DCs toward an anti-inflammatory profile with IL-10 production (27). Inflammasome activation can also occur through destabilization and rupture of the lysosome following phagocytosis. Indeed, the lysosome compartment is the most described intracellular site of NP sequestration following endocytosis (28). Morishige et al. (29) demonstrated in THP-1 cells that aSNP could induce ROS production, triggered endosomal rupture followed by the activation of NLRP3 inflammasome, and subsequent IL-1-β production (29). These authors therefore established a direct relationship between oxidative stress and IL-1-β secretion. Nano TiO2 and nano SiO2 particles activate the NLRP3 inflammasome in THP-1 cells, correlated with induction of lung inflammation in  vivo requiring IL-1 receptor expression (30). Inflammasome activation by nano TiO2 and nano SiO2 particles would occur through ATP release and adenosine receptor signaling (30, 31). Moreover, 30 nm silica NPs can induce intracellular ATP release and P2X7 receptors purinergic signaling, leading to\nFrontiers in Immunology | www.frontiersin.org May 2017 | Volume 8 | Article 544\nROS production, inflammasome activation and stimulating the production of IL-1β and IL-18 in LPS-matured murine BM-DC (32).\nPROTein AGGReGATeS, AS nPs, CAn DRive iMMUne ReSPOnSeS\nBeyond the strict definition of NPs, we should also consider nanomaterials in a broader sense of the term, since other structures than those derived from nanotechnologies could interact with the immune system (33). The example of protein aggregates is deeply studied as therapeutic bioproducts (BP) have a propensity to form oligomeric structures that could be assimilated to NPs. It is now well accepted that aggregation of therapeutic proteins is associated with increased potential for immunogenicity in patients, leading to the development of antidrug antibodies (34, 35). While the aggregation process is strictly followed and controlled during BP manufacturing process, using orthogonal analysis methods (36), this is no more the case over transportation, storage, and administration procedures. Several studies have shown that under accelerated stress conditions, proteins can give mixtures of soluble aggregates that are submicron species including oligomers or multimers, mostly detected with dynamic light scattering method, and insoluble aggregates that are above the micrometer range (37). This was the case for human growth hormone submitted to a stir stress that gave homogenous aggregates around 892  nm (38), or antibody preparations that underwent stir stress (39), or thermal stress (40, 41). Another study showed the appearance of nanosized antibody aggregates upon heat or pH-shift stress that persisted when preparations were diluted in human serum, highlighting the interactions of aggregated proteins with biological fluids (42). A classification scheme was proposed for antibodies aggregates, based on several biophysical characterizations, in which nanosized particles were present in most of the depicted classes (43), although they were more represented in the subclass showing “small, partially folded and partially reversible” aggregates (43). Moreover, protein aggregation can be promoted by the presence of some other nanosized particles, such as glass (44), tungsten (45), or leaching from vial stoppers, as hypothesized in the early 2000s, regarding the episode of increased pure red-cell aplasia cases in patients treated with epoietin alpha (46). Such cases were shown to be mediated by anti-erythropoietin antibodies cross-reacting with the endogenous protein. Several models highlighting protein interactions and aggregation promoted by shedding particles from administration materials have been described (47–49).\nThe effect of protein aggregates on the immune system can be evaluated using in vivo models, such as immune-tolerant transgenic mice that can be treated with the human native or aggregated recombinant protein. Immunogenicity is then assessed following IgG titers developed against the administrated component. Such transgenic mice models have been developed for interferons (50, 51), and a recent paper showed that recombinant interferon beta aggregates induced a break of immune tolerance in transgenic mice, related with the size and structure of the generated aggregates (52). Using a conventional murine model,\nanother study highlighted that oligomeric antibody aggregates were more immunogenic than larger highly aggregated particles (41), suggesting that protein aggregation that maintains some native epitopes is more immunogenic. However, the use of in vitro models is more convenient to test the effect of aggregated proteins on immune cells. Thus, antibody aggregates have the potential to increase the production of inflammatory cytokines by human PBMC (53). Testing these aggregates by size showed that nanosized particles induced a lower response than microsized particles (54). The current hypothesis is that aggregates could behave as danger signals and may have mainly an effect on antigen-presenting cells, such as monocytes or DC (Figure 1). This hypothesis was objectivized demonstrating that aggregates interaction with PBMC or primary monocytes is partly mediated by toll-like receptors (TLR2 and TLR4), although other receptors such as Fc or complement receptors are also involved (53, 55). DCs are innate immune cells in first line upon therapeutic protein administration, either by intramuscular, intravenous, or subcutaneous administration, as proteins and aggregates rapidly transit in lymph nodes and interact with resident DCs. Also, cutaneous DCs that are present in the point of injection area could be recruited and migrate to peripheral lymph nodes (56). As therapeutic proteins can be processed by DCs to be presented to T cells, aggregates can interact with pattern recognition receptors, and then induce DCs activation. Indeed, several studies have shown that antibodies or growth hormone (GH) aggregates have the capacity to induce monocyte-derived dendritic cells maturation, evidenced by an increase in phenotypic markers expression, as well as cytokine or chemokine production (38, 57, 58). Both GH and antibodies aggregates could induce the production of IL-6, IL-8, IL-12p40, and CXCL10 whereas CCL2, CCL3, CCL4 production was only seen with GH aggregates (38). These observations could be extended using the monocytic cell line THP-1, that secreted inflammatory cytokines upon incubation with aggregated intravenous immunoglobulin preparations (55). Antibody aggregates are able to induce an increase in CD4+  T-cell proliferation and to drive T-cell polarization, compared to native counterparts through DCs phenotype modifications (38, 53, 57, 58). Cellular mechanisms by which protein aggregates induce DCs maturation remain to be clarified; however, a few elements are available. It was determined that DCs in contact with aggregates presented a higher number and different class II HLA-associated peptides than native counterparts, suggesting different processing and presentation, and thus neo-epitopes presentation (57). Although internalization in DCs lysosomal compartment of aggregated antibodies has been evidenced (58), the exact mechanism, either phagocytosis or macropinocytosis remains to be elucidated. Both certainly take place, depending on the size of the particles (20, 59, 60)."
    }, {
      "heading" : "COnCLUSiOn",
      "text" : "Why the immune system should be concerned by nanomaterials? From the literature, it is now clear that exposure to environmental particles can exacerbate or participate to allergic manifestations such as asthma or rhinitis. Diesel exhaust particles and, more\nFrontiers in Immunology | www.frontiersin.org May 2017 | Volume 8 | Article 544\nrecently, products generated through the use of nanotechnology have been shown to have detrimental effects on the respiratory systems, with an exacerbation rate of asthma (61). Nanomaterials can alter in  vitro and in  vivo responses of the immune system to allergens and can also play a role in allergen sensitization. Mimicking danger signals can lead to a direct effect of DCs phenotype (Figure 1) having consequences on the adaptive immune system response and recognition of allergens. The recent advances in nanotechnology could also lead to unforeseen adverse health effects mediated by the immune system, nanoimmunosafety, in exposed human subjects (62)."
    }, {
      "heading" : "AUTHOR COnTRiBUTiOnS",
      "text" : "MP organized the manuscript and wrote the general part. AB-V wrote the nanomaterial part of the article. IT wrote the “aggregates” part of the article."
    }, {
      "heading" : "FUnDinG",
      "text" : "This work is supported by Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (ANSES) grant SILIMMUN."
    } ],
    "references" : [ {
      "title" : "Nanoparticle uptake: the phagocyte problem",
      "author" : [ "HH Gustafson", "D Holt-Casper", "DW Grainger", "H. Ghandehari" ],
      "venue" : "Nano Today",
      "citeRegEx" : "1",
      "shortCiteRegEx" : "1",
      "year" : 2015
    }, {
      "title" : "Macrophage silica nanoparticle response is phenotypically dependent",
      "author" : [ "HL Herd", "KT Bartlett", "JA Gustafson", "LD McGill", "H. Ghandehari" ],
      "venue" : "Biomaterials",
      "citeRegEx" : "2",
      "shortCiteRegEx" : "2",
      "year" : 2015
    }, {
      "title" : "Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages",
      "author" : [ "DA Kuhn", "D Vanhecke", "B Michen", "F Blank", "P Gehr", "A Petri-Fink" ],
      "venue" : "Beilstein J Nanotechnol",
      "citeRegEx" : "3",
      "shortCiteRegEx" : "3",
      "year" : 2014
    }, {
      "title" : "Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro",
      "author" : [ "A Franca", "P Aggarwal", "EV Barsov", "SV Kozlov", "MA Dobrovolskaia", "A. GonzalezFernandez" ],
      "venue" : "Nanomedicine",
      "citeRegEx" : "4",
      "shortCiteRegEx" : "4",
      "year" : 2011
    }, {
      "title" : "Role of the scavenger receptor MARCO in alveolar macrophage binding of unopsonized environmental particles",
      "author" : [ "A Palecanda", "J Paulauskis", "E Al-Mutairi", "A Imrich", "G Qin", "H Suzuki" ],
      "venue" : "J Exp Med",
      "citeRegEx" : "5",
      "shortCiteRegEx" : "5",
      "year" : 1999
    }, {
      "title" : "Cellular recognition and trafficking of amorphous silica nanoparticles by macrophage scavenger receptor A",
      "author" : [ "GA Orr", "WB Chrisler", "KJ Cassens", "R Tan", "BJ Tarasevich", "LM Markillie" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "6",
      "shortCiteRegEx" : "6",
      "year" : 2011
    }, {
      "title" : "Mesoporous silica particles induce size dependent effects on human dendritic cells",
      "author" : [ "H Vallhov", "S Gabrielsson", "M Stromme", "A Scheynius", "AE. Garcia-Bennett" ],
      "venue" : "Nano Lett",
      "citeRegEx" : "7",
      "shortCiteRegEx" : "7",
      "year" : 2007
    }, {
      "title" : "Activation of the inflammasome by amorphous silica and TiO2 nanoparticles in murine dendritic cells",
      "author" : [ "M Winter", "HD Beer", "V Hornung", "U Kramer", "RP Schins", "I. Forster" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "8",
      "shortCiteRegEx" : "8",
      "year" : 2011
    }, {
      "title" : "The current state of nanoparticle-induced macrophage polarization and reprogramming research",
      "author" : [ "X Miao", "X Leng", "Q. Zhang" ],
      "venue" : "Int J Mol Sci (2017)",
      "citeRegEx" : "9",
      "shortCiteRegEx" : "9",
      "year" : 1802
    }, {
      "title" : "M2 polarization enhances silica nanoparticle uptake by macrophages",
      "author" : [ "J Hoppstadter", "M Seif", "A Dembek", "C Cavelius", "H Huwer", "A Kraegeloh" ],
      "venue" : "Front Pharmacol",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2015
    }, {
      "title" : "Biomolecular coronas provide the biological identity of nanosized materials",
      "author" : [ "MP Monopoli", "C Aberg", "A Salvati", "KA. Dawson" ],
      "venue" : "Nat Nanotechnol",
      "citeRegEx" : "11",
      "shortCiteRegEx" : "11",
      "year" : 2012
    }, {
      "title" : "The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) (2016",
      "author" : [ "C Corbo", "R Molinaro", "A Parodi", "NE Toledano Furman", "F Salvatore", "E. Tasciotti" ],
      "venue" : null,
      "citeRegEx" : "12",
      "shortCiteRegEx" : "12",
      "year" : 2016
    }, {
      "title" : "Protein bio-corona: critical issue in immune nanotoxicology",
      "author" : [ "M Neagu", "Z Piperigkou", "K Karamanou", "AB Engin", "AO Docea", "C Constantin" ],
      "venue" : "Arch Toxicol",
      "citeRegEx" : "13",
      "shortCiteRegEx" : "13",
      "year" : 2017
    }, {
      "title" : "It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system",
      "author" : [ "C Farrera", "B. Fadeel" ],
      "venue" : "Eur J Pharm Biopharm",
      "citeRegEx" : "14",
      "shortCiteRegEx" : "14",
      "year" : 2015
    }, {
      "title" : "Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration",
      "author" : [ "AA Kapralov", "WH Feng", "AA Amoscato", "N Yanamala", "K Balasubramanian", "DE Winnica" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "15",
      "shortCiteRegEx" : "15",
      "year" : 2012
    }, {
      "title" : "Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation",
      "author" : [ "ZJ Deng", "M Liang", "M Monteiro", "I Toth", "RF. Minchin" ],
      "venue" : "Nat Nanotechnol",
      "citeRegEx" : "16",
      "shortCiteRegEx" : "16",
      "year" : 2011
    }, {
      "title" : "Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses",
      "author" : [ "ZJ Deng", "M Liang", "I Toth", "M Monteiro", "RF. Minchin" ],
      "venue" : "Nanotoxicology",
      "citeRegEx" : "17",
      "shortCiteRegEx" : "17",
      "year" : 2013
    }, {
      "title" : "Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials",
      "author" : [ "GM Mortimer", "NJ Butcher", "AW Musumeci", "ZJ Deng", "DJ Martin", "RF. Minchin" ],
      "venue" : "ACS Nano",
      "citeRegEx" : "18",
      "shortCiteRegEx" : "18",
      "year" : 2014
    }, {
      "title" : "Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation",
      "author" : [ "E Seydoux", "B Rothen-Rutishauser", "IM Nita", "S Balog", "A Gazdhar", "PA Stumbles" ],
      "venue" : "Int J Nanomedicine",
      "citeRegEx" : "19",
      "shortCiteRegEx" : "19",
      "year" : 2014
    }, {
      "title" : "Nanoparticles target distinct dendritic cell populations according to their size",
      "author" : [ "V Manolova", "A Flace", "M Bauer", "K Schwarz", "P Saudan", "MF. Bachmann" ],
      "venue" : "Eur J Immunol",
      "citeRegEx" : "20",
      "shortCiteRegEx" : "20",
      "year" : 2008
    }, {
      "title" : "Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells",
      "author" : [ "E Koike", "H Takano", "K Inoue", "R Yanagisawa", "T. Kobayashi" ],
      "venue" : null,
      "citeRegEx" : "21",
      "shortCiteRegEx" : "21",
      "year" : 2008
    }, {
      "title" : "The induction of maturation on dendritic cells by TiO2 and Fe(3)O(4)@TiO(2) nanoparticles via NF-kappaB signaling pathway",
      "author" : [ "R Zhu", "Y Zhu", "M Zhang", "Y Xiao", "X Du", "H Liu" ],
      "venue" : "Mater Sci Eng C Mater Biol Appl",
      "citeRegEx" : "22",
      "shortCiteRegEx" : "22",
      "year" : 2014
    }, {
      "title" : "Induction of functional changes of dendritic cells by silica nanoparticles",
      "author" : [ "Kang K", "Lim JS" ],
      "venue" : "Immune Netw",
      "citeRegEx" : "23",
      "shortCiteRegEx" : "23",
      "year" : 2012
    }, {
      "title" : "The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity",
      "author" : [ "PM Gallo", "S. Gallucci" ],
      "venue" : "Front Immunol",
      "citeRegEx" : "24",
      "shortCiteRegEx" : "24",
      "year" : 2013
    }, {
      "title" : "The danger theory: 20 years later",
      "author" : [ "Pradeu T", "Cooper EL" ],
      "venue" : "Front Immunol",
      "citeRegEx" : "25",
      "shortCiteRegEx" : "25",
      "year" : 2012
    }, {
      "title" : "Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line",
      "author" : [ "C Migdal", "J Botton", "Z El Ali", "ME Azoury", "J Guldemann", "E Gimenez-Arnau" ],
      "venue" : null,
      "citeRegEx" : "26",
      "shortCiteRegEx" : "26",
      "year" : 2013
    }, {
      "title" : "Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles",
      "author" : [ "BC Schanen", "S Das", "CM Reilly", "WL Warren", "WT Self", "S Seal" ],
      "venue" : "PLoS One",
      "citeRegEx" : "27",
      "shortCiteRegEx" : "27",
      "year" : 2013
    }, {
      "title" : "Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity",
      "author" : [ "ST Stern", "PP Adiseshaiah", "RM. Crist" ],
      "venue" : "Part Fibre Toxicol",
      "citeRegEx" : "28",
      "shortCiteRegEx" : "28",
      "year" : 2012
    }, {
      "title" : "Titanium dioxide induces different levels of IL-1beta production dependent on its particle characteristics through caspase-1 activation mediated by reactive oxygen species and cathepsin B",
      "author" : [ "T Morishige", "Y Yoshioka", "A Tanabe", "X Yao", "S Tsunoda", "Y Tsutsumi" ],
      "venue" : "Biochem Biophys Res Commun",
      "citeRegEx" : "29",
      "shortCiteRegEx" : "29",
      "year" : 2010
    }, {
      "title" : "Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1alpha and  6  Pallardy et al.  Immune System and Nanomaterials Frontiers in Immunology | www.frontiersin.org  May 2017 | Volume 8 | Article 544  IL-1beta",
      "author" : [ "AS Yazdi", "G Guarda", "N Riteau", "SK Drexler", "A Tardivel", "I Couillin" ],
      "venue" : null,
      "citeRegEx" : "30",
      "shortCiteRegEx" : "30",
      "year" : 2010
    }, {
      "title" : "The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine",
      "author" : [ "L Baron", "A Gombault", "M Fanny", "B Villeret", "F Savigny", "N Guillou" ],
      "venue" : "Cell Death Dis (2015) 6:e1629",
      "citeRegEx" : "31",
      "shortCiteRegEx" : "31",
      "year" : 2014
    }, {
      "title" : "Silica nanoparticles activate purinergic signaling via P2X7 receptor in dendritic cells, leading to production of pro-inflammatory cytokines",
      "author" : [ "K Nakanishi", "M Tsukimoto", "S Tanuma", "K Takeda", "S. Kojima" ],
      "venue" : "Toxicol In Vitro",
      "citeRegEx" : "32",
      "shortCiteRegEx" : "32",
      "year" : 2016
    }, {
      "title" : "Understanding the immunogenicity and antigenicity of nanomaterials: past, present and future",
      "author" : [ "Ilinskaya AN", "Dobrovolskaia MA" ],
      "venue" : "Toxicol Appl Pharmacol (2016)",
      "citeRegEx" : "33",
      "shortCiteRegEx" : "33",
      "year" : 2016
    }, {
      "title" : "Immunogenicity of therapeutic proteins: influence of aggregation",
      "author" : [ "KD Ratanji", "JP Derrick", "RJ Dearman", "I. Kimber" ],
      "venue" : "J Immunotoxicol",
      "citeRegEx" : "34",
      "shortCiteRegEx" : "34",
      "year" : 2014
    }, {
      "title" : "Immunogenicity of protein aggregates-concerns and realities",
      "author" : [ "W Wang", "SK Singh", "N Li", "MR Toler", "KR King", "S. Nema" ],
      "venue" : "Int J Pharm",
      "citeRegEx" : "35",
      "shortCiteRegEx" : "35",
      "year" : 2012
    }, {
      "title" : "Strategies for the assessment of protein aggregates in pharmaceutical biotech product development",
      "author" : [ "J den Engelsman", "P Garidel", "R Smulders", "H Koll", "B Smith", "S Bassarab" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "36",
      "shortCiteRegEx" : "36",
      "year" : 2011
    }, {
      "title" : "Protein aggregation: pathways, induction factors and analysis",
      "author" : [ "HC Mahler", "W Friess", "U Grauschopf", "S. Kiese" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "37",
      "shortCiteRegEx" : "37",
      "year" : 2009
    }, {
      "title" : "Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization",
      "author" : [ "Y Gallais", "N Szely", "FX Legrand", "A Leroy", "M Pallardy", "I. Turbica" ],
      "venue" : "Immunol Cell Biol (2016)",
      "citeRegEx" : "38",
      "shortCiteRegEx" : "38",
      "year" : 2016
    }, {
      "title" : "Induction and analysis of aggregates in a liquid IgG1-antibody formulation",
      "author" : [ "HC Mahler", "R Muller", "W Friess", "A Delille", "S. Matheus" ],
      "venue" : "Eur J Pharm Biopharm",
      "citeRegEx" : "39",
      "shortCiteRegEx" : "39",
      "year" : 2005
    }, {
      "title" : "Use of a folding model and in situ spectroscopic techniques for rational formulation development and stability testing of monoclonal antibody therapeutics",
      "author" : [ "G Rao", "V Iyer", "MP Kosloski", "DS Pisal", "E Shin", "CR Middaugh" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "40",
      "shortCiteRegEx" : "40",
      "year" : 2010
    }, {
      "title" : "The effect of small oligomeric protein aggregates on the immunogenicity of intravenous and subcutaneous administered antibodies",
      "author" : [ "AM Fathallah", "M Chiang", "A Mishra", "S Kumar", "L Xue", "R Middaugh" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "41",
      "shortCiteRegEx" : "41",
      "year" : 2015
    }, {
      "title" : "Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice",
      "author" : [ "V Filipe", "W Jiskoot", "AH Basmeleh", "A Halim", "H Schellekens", "V. Brinks" ],
      "venue" : "MAbs",
      "citeRegEx" : "42",
      "shortCiteRegEx" : "42",
      "year" : 2012
    }, {
      "title" : "Classification and characterization of therapeutic antibody aggregates",
      "author" : [ "MK Joubert", "Q Luo", "Y Nashed-Samuel", "J Wypych", "LO. Narhi" ],
      "venue" : "J Biol Chem",
      "citeRegEx" : "43",
      "shortCiteRegEx" : "43",
      "year" : 2011
    }, {
      "title" : "Glass particles as an adjuvant: a model for adverse immunogenicity of therapeutic proteins",
      "author" : [ "AH Fradkin", "JF Carpenter", "TW. Randolph" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "44",
      "shortCiteRegEx" : "44",
      "year" : 2011
    }, {
      "title" : "Tungsteninduced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity",
      "author" : [ "A Seidl", "O Hainzl", "M Richter", "R Fischer", "S Bohm", "B Deutel" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "45",
      "shortCiteRegEx" : "45",
      "year" : 2012
    }, {
      "title" : "Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin",
      "author" : [ "N Casadevall", "J Nataf", "B Viron", "A Kolta", "JJ Kiladjian", "P Martin-Dupont" ],
      "venue" : "N Engl J Med",
      "citeRegEx" : "46",
      "shortCiteRegEx" : "46",
      "year" : 2002
    }, {
      "title" : "Monoclonal antibody interactions with micro- and nanoparticles: adsorption, aggregation, and accelerated stress studies",
      "author" : [ "JS Bee", "D Chiu", "S Sawicki", "JL Stevenson", "K Chatterjee", "E Freund" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "47",
      "shortCiteRegEx" : "47",
      "year" : 2009
    }, {
      "title" : "Particles shed from syringe filters and their effects on agitation-induced protein aggregation",
      "author" : [ "L Liu", "TW Randolph", "JF. Carpenter" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "48",
      "shortCiteRegEx" : "48",
      "year" : 2012
    }, {
      "title" : "Effects of syringe material and silicone oil lubrication on the stability of pharmaceutical proteins",
      "author" : [ "E Krayukhina", "K Tsumoto", "S Uchiyama", "K. Fukui" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "49",
      "shortCiteRegEx" : "49",
      "year" : 2015
    }, {
      "title" : "Antibody response to aggregated human interferon alpha2b in wild-type and transgenic immune tolerant mice depends on type and level of aggregation",
      "author" : [ "S Hermeling", "H Schellekens", "C Maas", "MF Gebbink", "DJ Crommelin", "W. Jiskoot" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "50",
      "shortCiteRegEx" : "50",
      "year" : 2006
    }, {
      "title" : "Aggregated recombinant human interferon beta induces antibodies but no memory in immune-tolerant transgenic mice",
      "author" : [ "MM van Beers", "M Sauerborn", "F Gilli", "V Brinks", "H Schellekens", "W. Jiskoot" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "51",
      "shortCiteRegEx" : "51",
      "year" : 2010
    }, {
      "title" : "Immunogenicity of recombinant human interferon beta-1b in immunetolerant transgenic mice corresponds with the biophysical characteristics of aggregates",
      "author" : [ "MH Abdolvahab", "A Fazeli", "A Halim", "AS Sediq", "MR Fazeli", "H. Schellekens" ],
      "venue" : "J Interferon Cytokine Res",
      "citeRegEx" : "52",
      "shortCiteRegEx" : "52",
      "year" : 2015
    }, {
      "title" : "Highly aggregated antibody therapeutics can enhance the in vitro innate and late-stage T-cell immune responses",
      "author" : [ "MK Joubert", "M Hokom", "C Eakin", "L Zhou", "M Deshpande", "MP Baker" ],
      "venue" : "J Biol Chem",
      "citeRegEx" : "53",
      "shortCiteRegEx" : "53",
      "year" : 2012
    }, {
      "title" : "Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting",
      "author" : [ "S Telikepalli", "HE Shinogle", "PS Thapa", "JH Kim", "M Deshpande", "V Jawa" ],
      "venue" : "J Pharm Sci",
      "citeRegEx" : "54",
      "shortCiteRegEx" : "54",
      "year" : 2015
    }, {
      "title" : "Physical characterization and innate immunogenicity of aggregated intravenous immunoglobulin (IGIV) in an in vitro cell-based model",
      "author" : [ "EM Moussa", "J Kotarek", "JS Blum", "E Marszal", "EM. Topp" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "55",
      "shortCiteRegEx" : "55",
      "year" : 1914
    }, {
      "title" : "Immunogenicity of subcutaneously administered therapeutic proteins—a mechanistic perspective",
      "author" : [ "AM Fathallah", "RB Bankert", "SV. Balu-Iyer" ],
      "venue" : "AAPS J",
      "citeRegEx" : "56",
      "shortCiteRegEx" : "56",
      "year" : 2013
    }, {
      "title" : "Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro",
      "author" : [ "V Rombach-Riegraf", "AC Karle", "B Wolf", "L Sorde", "S Koepke", "S Gottlieb" ],
      "venue" : null,
      "citeRegEx" : "57",
      "shortCiteRegEx" : "57",
      "year" : 2014
    }, {
      "title" : "Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics",
      "author" : [ "M Ahmadi", "CJ Bryson", "EA Cloake", "K Welch", "V Filipe", "S Romeijn" ],
      "venue" : "Pharm Res",
      "citeRegEx" : "58",
      "shortCiteRegEx" : "58",
      "year" : 2015
    }, {
      "title" : "Engineered nanoparticles interacting with cells: size matters",
      "author" : [ "L Shang", "K Nienhaus", "GU. Nienhaus" ],
      "venue" : "J Nanobiotechnology",
      "citeRegEx" : "59",
      "shortCiteRegEx" : "59",
      "year" : 2014
    }, {
      "title" : "Sequence-dependent internalization of aggregating peptides",
      "author" : [ "JR Couceiro", "R Gallardo", "F De Smet", "G De Baets", "P Baatsen", "W Annaert" ],
      "venue" : "J Biol Chem",
      "citeRegEx" : "60",
      "shortCiteRegEx" : "60",
      "year" : 2015
    }, {
      "title" : "A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): why ambient ultrafine and engineered nanoparticles should receive special attention for possible adverse health outcomes in human subjects",
      "author" : [ "N Li", "S Georas", "N Alexis", "P Fritz", "T Xia", "MA Williams" ],
      "venue" : "J Allergy Clin Immunol",
      "citeRegEx" : "61",
      "shortCiteRegEx" : "61",
      "year" : 2016
    }, {
      "title" : "Assessing the immunosafety of engineered nanoparticles with a novel in vitro model based on human primary monocytes",
      "author" : [ "Y Li", "P Italiani", "E Casals", "D Valkenborg", "I Mertens", "G Baggerman" ],
      "venue" : "ACS Appl Mater Interfaces",
      "citeRegEx" : "62",
      "shortCiteRegEx" : "62",
      "year" : 2017
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "Macrophages are in charge of nanomaterials recognition, uptake, processing, and clearance (1).",
      "startOffset" : 90,
      "endOffset" : 93
    }, {
      "referenceID" : 0,
      "context" : "In these organs, fenestrated capillary beds, competent to capture particles, are associated with specialized macrophages populations (1).",
      "startOffset" : 133,
      "endOffset" : 136
    }, {
      "referenceID" : 1,
      "context" : "In mice injected with non-degradable silica NPs, a high accumulation in the liver and in the spleen was observed, in majority in the macrophages but also in neutrophils (2).",
      "startOffset" : 169,
      "endOffset" : 172
    }, {
      "referenceID" : 2,
      "context" : "These internalization processes are deeply dependent on nanomaterials properties such as size, shape, surface coating, and on the cellular environment (3).",
      "startOffset" : 151,
      "endOffset" : 154
    }, {
      "referenceID" : 0,
      "context" : "Due to their actin-based cytoskeleton rearrangement capacities, these cells can entrap the material through membrane dynamics in a zipper model fashion (1).",
      "startOffset" : 152,
      "endOffset" : 155
    }, {
      "referenceID" : 0,
      "context" : "The best characterized opsonin-dependent phagocytosis receptors are the Fcγ receptor and the complement receptor CR3, which appear to play a significant role in the detection of opsonized nanomaterials and in the rate of uptake (1).",
      "startOffset" : 228,
      "endOffset" : 231
    }, {
      "referenceID" : 3,
      "context" : "It was demonstrated that the small gold colloid NPs (30 nm) use several internalization routes (including scavenger receptor-, clathrin-, and caveolin-mediated pathways), in contrast to the larger materials of 150 nm which appear to be preferentially taken up via the scavenger receptor pathway (4).",
      "startOffset" : 295,
      "endOffset" : 298
    }, {
      "referenceID" : 4,
      "context" : "The scavenger receptor MARCO has been involved in the ingestion of unopsonized inhaled TiO2 and Fe2O3 particles in the lung (5).",
      "startOffset" : 124,
      "endOffset" : 127
    }, {
      "referenceID" : 5,
      "context" : "Moreover, the recognition of silica NPs by macrophages scavenger A receptor could induce the release of cytokines responsible for pulmonary inflammation (6).",
      "startOffset" : 153,
      "endOffset" : 156
    }, {
      "referenceID" : 6,
      "context" : "(7), an active mechanism such as endocytosis may be involved in the amorphous silica nanoparticle (aSNP) uptake by DCs (7).",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 6,
      "context" : "(7), an active mechanism such as endocytosis may be involved in the amorphous silica nanoparticle (aSNP) uptake by DCs (7).",
      "startOffset" : 119,
      "endOffset" : 122
    }, {
      "referenceID" : 7,
      "context" : "(8) additionally suggested that it would be at least partly mediated by an actin-dependent mechanism (8).",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 7,
      "context" : "(8) additionally suggested that it would be at least partly mediated by an actin-dependent mechanism (8).",
      "startOffset" : 101,
      "endOffset" : 104
    }, {
      "referenceID" : 8,
      "context" : "Nanomaterials can affect the polarization and the reprogramming of macrophages, mostly depending on chemical composition, size, and surface modification (9).",
      "startOffset" : 153,
      "endOffset" : 156
    }, {
      "referenceID" : 9,
      "context" : "In particular, silica NPs uptake is enhanced in M2-polarized primary human monocyte-derived macrophages or in the macrophage-like THP-1 cell line as compared with M1 cells (10).",
      "startOffset" : 172,
      "endOffset" : 176
    }, {
      "referenceID" : 10,
      "context" : "In vivo, upon exposure to biological fluids, NPs do not stay “naked” but become coated by biomolecules, primarily proteins but also sugars, lipids, or nucleic acids, forming a “corona” (11).",
      "startOffset" : 185,
      "endOffset" : 189
    }, {
      "referenceID" : 11,
      "context" : "If the “hard” corona is tightly bound with a long exchange time, the “soft” corona, presented as a second layer, is submitted to fast exchanges (12, 13).",
      "startOffset" : 144,
      "endOffset" : 152
    }, {
      "referenceID" : 12,
      "context" : "If the “hard” corona is tightly bound with a long exchange time, the “soft” corona, presented as a second layer, is submitted to fast exchanges (12, 13).",
      "startOffset" : 144,
      "endOffset" : 152
    }, {
      "referenceID" : 13,
      "context" : "Interestingly, this process could be compared to the opsonization of pathogens (14) and affects the efficiency of NPs uptake by macrophages.",
      "startOffset" : 79,
      "endOffset" : 83
    }, {
      "referenceID" : 14,
      "context" : "The presence of this coating noticeably enhanced the in vitro uptake of SWCNTs by macrophages (15).",
      "startOffset" : 94,
      "endOffset" : 98
    }, {
      "referenceID" : 13,
      "context" : "Moreover, proteins may undergo conformational changes, such as unfolding, leading to the possible exposition of cryptic epitopes recognized by immune cells (14).",
      "startOffset" : 156,
      "endOffset" : 160
    }, {
      "referenceID" : 15,
      "context" : "This unfolding was demonstrated with fibrinogen coated on negatively charged poly(acrylic acid) gold NPs, leading to MAC-1 receptor activation and pro-inflammatory cytokines secretion through NF-κB signaling (16).",
      "startOffset" : 208,
      "endOffset" : 212
    }, {
      "referenceID" : 16,
      "context" : "Interestingly, only the negatively charged NPs induced TNF-α and IL-8 release by THP-1 cells, whereas both positively and negatively charged particles could bind fibrinogen with high affinity (17).",
      "startOffset" : 192,
      "endOffset" : 196
    }, {
      "referenceID" : 17,
      "context" : "This protein corona is essential for scavenger receptor-efficient internalization of synthetic-layered silicate NPs by THP-1 cells (18).",
      "startOffset" : 131,
      "endOffset" : 135
    }, {
      "referenceID" : 17,
      "context" : "When bound to these NPs, albumin undergoes unfolding, comparable to heat denaturation, revealing a cryptic sequence allowing recognition of serum albumin by this family of receptors and nanomaterial recognition by macrophages (18).",
      "startOffset" : 226,
      "endOffset" : 230
    }, {
      "referenceID" : 18,
      "context" : "For example, in vivo, 20 nm polystyrene (PS) particles are more frequently captured by lung DCs than 1,000  nm PS particles (19).",
      "startOffset" : 124,
      "endOffset" : 128
    }, {
      "referenceID" : 18,
      "context" : "If the 20 nm PS particle in vitro treatment did not affect murine bone marrow-derived dendritic cells (BM-DCs) cell viability, maturation markers expression, and antigen uptake, these particles significantly downregulated antigen degradation in a size-dependent manner, in association with accumulation in lysosomes but without altering T-cell proliferation (19).",
      "startOffset" : 358,
      "endOffset" : 362
    }, {
      "referenceID" : 19,
      "context" : "Indeed, only small particles (20–200 nm) are able to drain freely to the lymph nodes (20).",
      "startOffset" : 85,
      "endOffset" : 89
    }, {
      "referenceID" : 20,
      "context" : "In murine BM-DCs, carbon black NPs upregulate the expression of the cell surface molecules CD86, and slightly CD80 and MHC-II molecules, associated with enhancement of allogenicmixed lymphocyte reaction (21).",
      "startOffset" : 203,
      "endOffset" : 207
    }, {
      "referenceID" : 21,
      "context" : "TiO2 NPs were also demonstrated to increase the expression of CD86, CD80, MHC-II, and TNF-α in murine BM-DCs (22).",
      "startOffset" : 109,
      "endOffset" : 113
    }, {
      "referenceID" : 22,
      "context" : "4, ultrafine silica NPs decreased cell viability, induced slight phenotypic changes but significantly increased TNF-α production in a size-dependent manner (23).",
      "startOffset" : 156,
      "endOffset" : 160
    }, {
      "referenceID" : 22,
      "context" : "org May 2017 | Volume 8 | Article 544 containing silica NPs (23).",
      "startOffset" : 60,
      "endOffset" : 64
    }, {
      "referenceID" : 7,
      "context" : "(8) studied the effects of aSNPs on murine BM-DCs.",
      "startOffset" : 0,
      "endOffset" : 3
    }, {
      "referenceID" : 7,
      "context" : "Activation of the NLRP3 inflammasome was also reported (8).",
      "startOffset" : 55,
      "endOffset" : 58
    }, {
      "referenceID" : 23,
      "context" : "As proposed by Gallo and Gallucci, “classic,” “homeostatic,” and “emerging” danger signals can be distinguished (24).",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 24,
      "context" : "Classic danger signals are derived from pathogens and released during infections (pathogen-associated molecular patterns) or result from tissue damage, released by necrotic dying cells (damageassociated molecular patterns or “alarmins”) (25).",
      "startOffset" : 237,
      "endOffset" : 241
    }, {
      "referenceID" : 25,
      "context" : "Chemical sensitizers involved in contact allergy have recently being found to modify the cutaneous microenvironment and/ or directly activate DCs resulting in DC phenotype modifications necessary for immune sensitization to these chemicals (26).",
      "startOffset" : 240,
      "endOffset" : 244
    }, {
      "referenceID" : 13,
      "context" : "Thus, it is postulated that immune cells could sense nanomaterials, which could be designated as nanoparticles-associated molecular patterns (Figure 1) as described for pathogens (14, 24).",
      "startOffset" : 179,
      "endOffset" : 187
    }, {
      "referenceID" : 23,
      "context" : "Thus, it is postulated that immune cells could sense nanomaterials, which could be designated as nanoparticles-associated molecular patterns (Figure 1) as described for pathogens (14, 24).",
      "startOffset" : 179,
      "endOffset" : 187
    }, {
      "referenceID" : 26,
      "context" : "Interestingly, TiO2 NPs, associated with the generation of ROS in human DCs, promoted cells maturation and pro-inflammatory cytokine release, whereas CeO2 NPs, possessing antioxidant properties, triggered human DCs toward an anti-inflammatory profile with IL-10 production (27).",
      "startOffset" : 273,
      "endOffset" : 277
    }, {
      "referenceID" : 27,
      "context" : "Indeed, the lysosome compartment is the most described intracellular site of NP sequestration following endocytosis (28).",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 28,
      "context" : "(29) demonstrated in THP-1 cells that aSNP could induce ROS production, triggered endosomal rupture followed by the activation of NLRP3 inflammasome, and subsequent IL-1-β production (29).",
      "startOffset" : 0,
      "endOffset" : 4
    }, {
      "referenceID" : 28,
      "context" : "(29) demonstrated in THP-1 cells that aSNP could induce ROS production, triggered endosomal rupture followed by the activation of NLRP3 inflammasome, and subsequent IL-1-β production (29).",
      "startOffset" : 183,
      "endOffset" : 187
    }, {
      "referenceID" : 29,
      "context" : "Nano TiO2 and nano SiO2 particles activate the NLRP3 inflammasome in THP-1 cells, correlated with induction of lung inflammation in  vivo requiring IL-1 receptor expression (30).",
      "startOffset" : 173,
      "endOffset" : 177
    }, {
      "referenceID" : 29,
      "context" : "Inflammasome activation by nano TiO2 and nano SiO2 particles would occur through ATP release and adenosine receptor signaling (30, 31).",
      "startOffset" : 126,
      "endOffset" : 134
    }, {
      "referenceID" : 30,
      "context" : "Inflammasome activation by nano TiO2 and nano SiO2 particles would occur through ATP release and adenosine receptor signaling (30, 31).",
      "startOffset" : 126,
      "endOffset" : 134
    }, {
      "referenceID" : 31,
      "context" : "org May 2017 | Volume 8 | Article 544 ROS production, inflammasome activation and stimulating the production of IL-1β and IL-18 in LPS-matured murine BM-DC (32).",
      "startOffset" : 156,
      "endOffset" : 160
    }, {
      "referenceID" : 32,
      "context" : "Beyond the strict definition of NPs, we should also consider nanomaterials in a broader sense of the term, since other structures than those derived from nanotechnologies could interact with the immune system (33).",
      "startOffset" : 209,
      "endOffset" : 213
    }, {
      "referenceID" : 33,
      "context" : "It is now well accepted that aggregation of therapeutic proteins is associated with increased potential for immunogenicity in patients, leading to the development of antidrug antibodies (34, 35).",
      "startOffset" : 186,
      "endOffset" : 194
    }, {
      "referenceID" : 34,
      "context" : "It is now well accepted that aggregation of therapeutic proteins is associated with increased potential for immunogenicity in patients, leading to the development of antidrug antibodies (34, 35).",
      "startOffset" : 186,
      "endOffset" : 194
    }, {
      "referenceID" : 35,
      "context" : "While the aggregation process is strictly followed and controlled during BP manufacturing process, using orthogonal analysis methods (36), this is no more the case over transportation, storage, and administration procedures.",
      "startOffset" : 133,
      "endOffset" : 137
    }, {
      "referenceID" : 36,
      "context" : "Several studies have shown that under accelerated stress conditions, proteins can give mixtures of soluble aggregates that are submicron species including oligomers or multimers, mostly detected with dynamic light scattering method, and insoluble aggregates that are above the micrometer range (37).",
      "startOffset" : 294,
      "endOffset" : 298
    }, {
      "referenceID" : 37,
      "context" : "This was the case for human growth hormone submitted to a stir stress that gave homogenous aggregates around 892  nm (38), or antibody preparations that underwent stir stress (39), or thermal stress (40, 41).",
      "startOffset" : 117,
      "endOffset" : 121
    }, {
      "referenceID" : 38,
      "context" : "This was the case for human growth hormone submitted to a stir stress that gave homogenous aggregates around 892  nm (38), or antibody preparations that underwent stir stress (39), or thermal stress (40, 41).",
      "startOffset" : 175,
      "endOffset" : 179
    }, {
      "referenceID" : 39,
      "context" : "This was the case for human growth hormone submitted to a stir stress that gave homogenous aggregates around 892  nm (38), or antibody preparations that underwent stir stress (39), or thermal stress (40, 41).",
      "startOffset" : 199,
      "endOffset" : 207
    }, {
      "referenceID" : 40,
      "context" : "This was the case for human growth hormone submitted to a stir stress that gave homogenous aggregates around 892  nm (38), or antibody preparations that underwent stir stress (39), or thermal stress (40, 41).",
      "startOffset" : 199,
      "endOffset" : 207
    }, {
      "referenceID" : 41,
      "context" : "Another study showed the appearance of nanosized antibody aggregates upon heat or pH-shift stress that persisted when preparations were diluted in human serum, highlighting the interactions of aggregated proteins with biological fluids (42).",
      "startOffset" : 236,
      "endOffset" : 240
    }, {
      "referenceID" : 42,
      "context" : "A classification scheme was proposed for antibodies aggregates, based on several biophysical characterizations, in which nanosized particles were present in most of the depicted classes (43), although they were more represented in the subclass showing “small, partially folded and partially reversible” aggregates (43).",
      "startOffset" : 186,
      "endOffset" : 190
    }, {
      "referenceID" : 42,
      "context" : "A classification scheme was proposed for antibodies aggregates, based on several biophysical characterizations, in which nanosized particles were present in most of the depicted classes (43), although they were more represented in the subclass showing “small, partially folded and partially reversible” aggregates (43).",
      "startOffset" : 314,
      "endOffset" : 318
    }, {
      "referenceID" : 43,
      "context" : "Moreover, protein aggregation can be promoted by the presence of some other nanosized particles, such as glass (44), tungsten (45), or leaching from vial stoppers, as hypothesized in the early 2000s, regarding the episode of increased pure red-cell aplasia cases in patients treated with epoietin alpha (46).",
      "startOffset" : 111,
      "endOffset" : 115
    }, {
      "referenceID" : 44,
      "context" : "Moreover, protein aggregation can be promoted by the presence of some other nanosized particles, such as glass (44), tungsten (45), or leaching from vial stoppers, as hypothesized in the early 2000s, regarding the episode of increased pure red-cell aplasia cases in patients treated with epoietin alpha (46).",
      "startOffset" : 126,
      "endOffset" : 130
    }, {
      "referenceID" : 45,
      "context" : "Moreover, protein aggregation can be promoted by the presence of some other nanosized particles, such as glass (44), tungsten (45), or leaching from vial stoppers, as hypothesized in the early 2000s, regarding the episode of increased pure red-cell aplasia cases in patients treated with epoietin alpha (46).",
      "startOffset" : 303,
      "endOffset" : 307
    }, {
      "referenceID" : 49,
      "context" : "Such transgenic mice models have been developed for interferons (50, 51), and a recent paper showed that recombinant interferon beta aggregates induced a break of immune tolerance in transgenic mice, related with the size and structure of the generated aggregates (52).",
      "startOffset" : 64,
      "endOffset" : 72
    }, {
      "referenceID" : 50,
      "context" : "Such transgenic mice models have been developed for interferons (50, 51), and a recent paper showed that recombinant interferon beta aggregates induced a break of immune tolerance in transgenic mice, related with the size and structure of the generated aggregates (52).",
      "startOffset" : 64,
      "endOffset" : 72
    }, {
      "referenceID" : 51,
      "context" : "Such transgenic mice models have been developed for interferons (50, 51), and a recent paper showed that recombinant interferon beta aggregates induced a break of immune tolerance in transgenic mice, related with the size and structure of the generated aggregates (52).",
      "startOffset" : 264,
      "endOffset" : 268
    }, {
      "referenceID" : 40,
      "context" : "Using a conventional murine model, another study highlighted that oligomeric antibody aggregates were more immunogenic than larger highly aggregated particles (41), suggesting that protein aggregation that maintains some native epitopes is more immunogenic.",
      "startOffset" : 159,
      "endOffset" : 163
    }, {
      "referenceID" : 52,
      "context" : "Thus, antibody aggregates have the potential to increase the production of inflammatory cytokines by human PBMC (53).",
      "startOffset" : 112,
      "endOffset" : 116
    }, {
      "referenceID" : 53,
      "context" : "Testing these aggregates by size showed that nanosized particles induced a lower response than microsized particles (54).",
      "startOffset" : 116,
      "endOffset" : 120
    }, {
      "referenceID" : 52,
      "context" : "This hypothesis was objectivized demonstrating that aggregates interaction with PBMC or primary monocytes is partly mediated by toll-like receptors (TLR2 and TLR4), although other receptors such as Fc or complement receptors are also involved (53, 55).",
      "startOffset" : 243,
      "endOffset" : 251
    }, {
      "referenceID" : 54,
      "context" : "This hypothesis was objectivized demonstrating that aggregates interaction with PBMC or primary monocytes is partly mediated by toll-like receptors (TLR2 and TLR4), although other receptors such as Fc or complement receptors are also involved (53, 55).",
      "startOffset" : 243,
      "endOffset" : 251
    }, {
      "referenceID" : 55,
      "context" : "Also, cutaneous DCs that are present in the point of injection area could be recruited and migrate to peripheral lymph nodes (56).",
      "startOffset" : 125,
      "endOffset" : 129
    }, {
      "referenceID" : 37,
      "context" : "Indeed, several studies have shown that antibodies or growth hormone (GH) aggregates have the capacity to induce monocyte-derived dendritic cells maturation, evidenced by an increase in phenotypic markers expression, as well as cytokine or chemokine production (38, 57, 58).",
      "startOffset" : 261,
      "endOffset" : 273
    }, {
      "referenceID" : 56,
      "context" : "Indeed, several studies have shown that antibodies or growth hormone (GH) aggregates have the capacity to induce monocyte-derived dendritic cells maturation, evidenced by an increase in phenotypic markers expression, as well as cytokine or chemokine production (38, 57, 58).",
      "startOffset" : 261,
      "endOffset" : 273
    }, {
      "referenceID" : 57,
      "context" : "Indeed, several studies have shown that antibodies or growth hormone (GH) aggregates have the capacity to induce monocyte-derived dendritic cells maturation, evidenced by an increase in phenotypic markers expression, as well as cytokine or chemokine production (38, 57, 58).",
      "startOffset" : 261,
      "endOffset" : 273
    }, {
      "referenceID" : 37,
      "context" : "Both GH and antibodies aggregates could induce the production of IL-6, IL-8, IL-12p40, and CXCL10 whereas CCL2, CCL3, CCL4 production was only seen with GH aggregates (38).",
      "startOffset" : 167,
      "endOffset" : 171
    }, {
      "referenceID" : 54,
      "context" : "These observations could be extended using the monocytic cell line THP-1, that secreted inflammatory cytokines upon incubation with aggregated intravenous immunoglobulin preparations (55).",
      "startOffset" : 183,
      "endOffset" : 187
    }, {
      "referenceID" : 37,
      "context" : "Antibody aggregates are able to induce an increase in CD4+  T-cell proliferation and to drive T-cell polarization, compared to native counterparts through DCs phenotype modifications (38, 53, 57, 58).",
      "startOffset" : 183,
      "endOffset" : 199
    }, {
      "referenceID" : 52,
      "context" : "Antibody aggregates are able to induce an increase in CD4+  T-cell proliferation and to drive T-cell polarization, compared to native counterparts through DCs phenotype modifications (38, 53, 57, 58).",
      "startOffset" : 183,
      "endOffset" : 199
    }, {
      "referenceID" : 56,
      "context" : "Antibody aggregates are able to induce an increase in CD4+  T-cell proliferation and to drive T-cell polarization, compared to native counterparts through DCs phenotype modifications (38, 53, 57, 58).",
      "startOffset" : 183,
      "endOffset" : 199
    }, {
      "referenceID" : 57,
      "context" : "Antibody aggregates are able to induce an increase in CD4+  T-cell proliferation and to drive T-cell polarization, compared to native counterparts through DCs phenotype modifications (38, 53, 57, 58).",
      "startOffset" : 183,
      "endOffset" : 199
    }, {
      "referenceID" : 56,
      "context" : "It was determined that DCs in contact with aggregates presented a higher number and different class II HLA-associated peptides than native counterparts, suggesting different processing and presentation, and thus neo-epitopes presentation (57).",
      "startOffset" : 238,
      "endOffset" : 242
    }, {
      "referenceID" : 57,
      "context" : "Although internalization in DCs lysosomal compartment of aggregated antibodies has been evidenced (58), the exact mechanism, either phagocytosis or macropinocytosis remains to be elucidated.",
      "startOffset" : 98,
      "endOffset" : 102
    }, {
      "referenceID" : 19,
      "context" : "Both certainly take place, depending on the size of the particles (20, 59, 60).",
      "startOffset" : 66,
      "endOffset" : 78
    }, {
      "referenceID" : 58,
      "context" : "Both certainly take place, depending on the size of the particles (20, 59, 60).",
      "startOffset" : 66,
      "endOffset" : 78
    }, {
      "referenceID" : 59,
      "context" : "Both certainly take place, depending on the size of the particles (20, 59, 60).",
      "startOffset" : 66,
      "endOffset" : 78
    }, {
      "referenceID" : 60,
      "context" : "org May 2017 | Volume 8 | Article 544 recently, products generated through the use of nanotechnology have been shown to have detrimental effects on the respiratory systems, with an exacerbation rate of asthma (61).",
      "startOffset" : 209,
      "endOffset" : 213
    }, {
      "referenceID" : 61,
      "context" : "The recent advances in nanotechnology could also lead to unforeseen adverse health effects mediated by the immune system, nanoimmunosafety, in exposed human subjects (62).",
      "startOffset" : 166,
      "endOffset" : 170
    }, {
      "referenceID" : 6,
      "context" : "Nanomedicine (Lond) (2011) 6(7):1175–88.",
      "startOffset" : 28,
      "endOffset" : 31
    }, {
      "referenceID" : 0,
      "context" : "Nanomedicine (Lond) (2016) 11(1):81–100.",
      "startOffset" : 29,
      "endOffset" : 32
    }, {
      "referenceID" : 2,
      "context" : "The induction of maturation on dendritic cells by TiO2 and Fe(3)O(4)@TiO(2) nanoparticles via NF-kappaB signaling pathway.",
      "startOffset" : 61,
      "endOffset" : 64
    }, {
      "referenceID" : 3,
      "context" : "The induction of maturation on dendritic cells by TiO2 and Fe(3)O(4)@TiO(2) nanoparticles via NF-kappaB signaling pathway.",
      "startOffset" : 65,
      "endOffset" : 68
    }, {
      "referenceID" : 1,
      "context" : "The induction of maturation on dendritic cells by TiO2 and Fe(3)O(4)@TiO(2) nanoparticles via NF-kappaB signaling pathway.",
      "startOffset" : 72,
      "endOffset" : 75
    }, {
      "referenceID" : 0,
      "context" : "Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles.",
      "startOffset" : 32,
      "endOffset" : 35
    }, {
      "referenceID" : 1,
      "context" : "Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles.",
      "startOffset" : 38,
      "endOffset" : 41
    }, {
      "referenceID" : 1,
      "context" : "Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles.",
      "startOffset" : 70,
      "endOffset" : 73
    }, {
      "referenceID" : 1,
      "context" : "Immunomodulation and T helper TH(1)/TH(2) response polarization by CeO(2) and TiO(2) nanoparticles.",
      "startOffset" : 81,
      "endOffset" : 84
    }, {
      "referenceID" : 44,
      "context" : "Proc Natl Acad Sci U S A (2010) 107(45):19449–54.",
      "startOffset" : 35,
      "endOffset" : 39
    }, {
      "referenceID" : 2,
      "context" : "Immunol Cell Biol (2016) 95(3):306–15.",
      "startOffset" : 27,
      "endOffset" : 30
    }, {
      "referenceID" : 2,
      "context" : "Eur J Pharm Biopharm (2005) 59(3):407–17.",
      "startOffset" : 30,
      "endOffset" : 33
    }, {
      "referenceID" : 3,
      "context" : "J Interferon Cytokine Res (2016) 36(4):247–57.",
      "startOffset" : 35,
      "endOffset" : 38
    }, {
      "referenceID" : 1,
      "context" : "J Allergy Clin Immunol (2016) 138(2):386–96.",
      "startOffset" : 33,
      "endOffset" : 36
    }, {
      "referenceID" : 41,
      "context" : "ACS Appl Mater Interfaces (2016) 8(42):28437–47.",
      "startOffset" : 34,
      "endOffset" : 38
    } ],
    "year" : 2017,
    "abstractText" : "Particles possess huge specific surface area and therefore nanomaterials exhibit unique characteristics, such as special physical properties and chemical hyper-reactivity, which make them particularly attractive but also raise numerous questions concerning their safety. Interactions of nanomaterials with the immune system can potentially lead to immunosuppression, hypersensitivity (allergy), immunogenicity and autoimmunity, involving both innate and adaptive immune responses. Inherent physical and chemical NP characteristics may influence their immunotoxicity, i.e., the adverse effects that can result from exposure. This review will focus on the possible interaction of nanomaterials including protein aggregates with the innate immune system with specific emphasis on antigen-presenting cells, i.e., dendritic cells, macrophages and monocytes.",
    "creator" : "Adobe InDesign CS6 (Windows)"
  }
}